Vikram Sudarsan

Vikram Sudarsan is an accomplished leader in the pharmaceutical and biotech industries with significant experience in executive roles. Currently serving as President and CEO at Engrail Therapeutics since July 2019, Vikram is also a co-founder of the company and a board member at EXCIVA GmbH. Prior experiences include key positions such as Member of the Board of Directors at CIPLA USA, Strategy Head for Cipla New Ventures, and CEO of Cipla Technologies, LLC. Vikram has held various board memberships and consulting roles, specializing in market access, business development, and technology benchmarking. Educational credentials include a Postdoc in Neurobiology from Stanford University School of Medicine and a PhD in Genetics from The University of Sheffield.